Acarodermatitis and Paroxysmal supraventricular tachycardia

Summary:

Paroxysmal supraventricular tachycardia is reported only by a few people with Acarodermatitis.

The study analyzes which people have Paroxysmal supraventricular tachycardia with Acarodermatitis. It is created by eHealthMe based on 5 people who have Paroxysmal supraventricular tachycardia and Acarodermatitis from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 19, 2022

5 people who have Acarodermatitis and Paroxysmal Supraventricular Tachycardia are studied.


What is Acarodermatitis?

Acarodermatitis (skin inflammation caused by mites (acarids)) is found to be associated with 479 drugs and 273 conditions by eHealthMe.

What is Paroxysmal supraventricular tachycardia?

Paroxysmal supraventricular tachycardia is found to be associated with 2,241 drugs and 1,583 conditions by eHealthMe.

Number of Paroxysmal supraventricular tachycardia in Acarodermatitis reports submitted per year:

Would you have Paroxysmal supraventricular tachycardia when you have Acarodermatitis?

Gender of people who have Acarodermatitis and experienced Paroxysmal Supraventricular Tachycardia *:

  • female: 80 %
  • male: 20 %

Age of people who have Acarodermatitis and experienced Paroxysmal Supraventricular Tachycardia *:

  • 0-1: 0.0 %
  • 2-9: 20 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 80 %

Common co-existing conditions for these people *:

  1. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 20.00%
  2. High Blood Pressure: 1 person, 20.00%
  3. Diabetes: 1 person, 20.00%

Common drugs taken by these people *:

  1. Stromectol: 5 people, 100.00%
  2. Levothyroxine Sodium: 1 person, 20.00%
  3. Furosemide: 1 person, 20.00%
  4. Avandia: 1 person, 20.00%
  5. Amlodipine Besylate: 1 person, 20.00%

Common symptoms for these people *:

  1. Crepitations (noises are produced by the rubbing of parts one against the other): 4 people, 80.00%
  2. Asthma: 4 people, 80.00%
  3. Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 1 person, 20.00%
  4. Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 20.00%
  5. Enlarged Heart: 1 person, 20.00%
  6. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 20.00%
  7. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 20.00%
  8. Cardiac Failure Congestive: 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Paroxysmal supraventricular tachycardia?

Check whether Paroxysmal supraventricular tachycardia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Paroxysmal supraventricular tachycardia:

Common drugs associated with Paroxysmal supraventricular tachycardia:

All the drugs that are associated with Paroxysmal supraventricular tachycardia:

Common conditions associated with Paroxysmal supraventricular tachycardia:

All the conditions that are associated with Paroxysmal supraventricular tachycardia:

How the study uses the data?

The study is based on Paroxysmal supraventricular tachycardia and Acarodermatitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: